Zobrazeno 1 - 10
of 44
pro vyhledávání: '"J. D. Harkins"'
Autor:
D.E. Granstrom, Shannon K. Reed, C. B. Baker, W. G. Carter, L. Dirikolu, B. G. Bentz, C. Wulff-Strobel, William J. Saville, S. McCrillis, Neil M. Williams, J. D. Harkins, Thomas Tobin, W. V. Bernard
Publikováno v:
Equine Veterinary Education. 12:195-200
Autor:
Andreas F. Lehner, J. Boyles, W. E. Woods, J. D. Harkins, David J. Schaeffer, Thomas Tobin, M. Fisher, Levent Dirikolu
Publikováno v:
Journal of Veterinary Pharmacology and Therapeutics. 32:271-279
Injuries sustained by horses during racing have been considered as an unavoidable part of horse racing. Many factors may be associated with the musculoskeletal injuries of Thoroughbred race horses. This study surveyed the amounts of nonsteroidal anti
Autor:
Richard S. Gates, Thomas Tobin, M. Fisher, Andreas F. Lehner, W. E. Woods, Levent Dirikolu, W. Karpiesiuk, J. D. Harkins
Publikováno v:
Journal of Veterinary Pharmacology and Therapeutics. 32:66-78
Pyrilamine is an antihistamine used in human and veterinary medicine. As antihistamines produce central nervous system effects in horses, pyrilamine has the potential to affect the performance of racehorses. In the present study, O-desmethylpyrilamin
Autor:
J. D. Harkins, F. C. Camargo, P. Detolve, Andreas F. Lehner, Frederik J. Derksen, Susan W. Eberhart, C. Berney, S. Baker, N. E. Robinson, Thomas Tobin
Publikováno v:
Equine Veterinary Journal. 38:563-569
Summary Reason for performing study: Trimetoquinol (TMQ) is a potent β-adrenoceptor agonist bronchodilator used in human medicine but has not been evaluated for potential use as a therapeutic agent for horses with ‘heaves’. Objectives: To assess
Autor:
Andreas F. Lehner, J. Boyles, L. Dirikolu, W. Karpiesiuk, W. E. Woods, Charlie Hughes, F. C. Camargo, Thomas Tobin, Jeffrey M. Bosken, A. Troppmann, J. D. Harkins
Publikováno v:
Journal of Analytical Toxicology. 28:553-562
Amitraz (N'-(2,4-dimethylphenyl)-N-[[(2,4-dimethylphenyl)imino]methyl]-N-methyl-methanimidamide) is an alpha-2 adrenergic agonist used in veterinary medicine primarily as a scabicide- or acaricide-type insecticide. As an alpha-2 adrenergic agonist, i
Autor:
W. E. Woods, Andreas F. Lehner, W. Karpiesiuk, J. Boyles, Charlie Hughes, J. D. Harkins, Thomas Tobin, F. C. Camargo
Publikováno v:
Chromatographia. 60:371-378
Trimetoquinol (TMQ) (1-(3’,4’,5’-trimethoxybenzyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, m.w. 345) is the prototype tetrahydroisoquinoline pharmaceutical. TMQ is marketed as a bronchodilator in human medicine; in horse racing, TMQ is li
Autor:
W. Karpiesiuk, Charlie Hughes, W. E. Woods, J. D. Harkins, A. Troppmann, Thomas Tobin, J. Bosken, F. C. Camargo, Andreas F. Lehner, J. Boyles
Publikováno v:
Chromatographia. 59:S79-S84
Salmeterol is a β2-adrenergic agonist and an Association of Racing Commissioners International (ARCI) class 3 drug. Trade names of its xinafoate salt are Arial (Dompe), Salmetedur (Menarini), and Serevent (Glaxo). Salmeterol is routinely used to inc
Autor:
W. Karpiesiuk, Andreas F. Lehner, J. Boyles, W. E. Woods, F. C. Camargo, J. D. Harkins, Charlie Hughes, Thomas Tobin
Publikováno v:
Chromatographia. 59:S95-S103
Dizocilpine ([+]-10,11-dihydro-5-methyl-5H-dibenzo[a,d]cyclohepten-5,10-imine), is a potent and selective NMDA (N-methyl-D-aspartate) receptor antagonist, which acts by blocking receptor ion channels. Dizocilpine is pharmacologically related to ketam
Autor:
N. E. Robinson, Andreas F. Lehner, Thomas Tobin, W. E. Woods, M. Fisher, W. Karpiesiuk, J. D. Harkins, L. Dirikolu
Publikováno v:
Journal of Analytical Toxicology. 25:280-287
Clenbuterol is a beta2 agonist/antagonist bronchodilator, and its identification in post-race samples may lead to sanctions. The objective of this study was to develop a specific and highly sensitive serum quantitation method for clenbuterol that wou
Autor:
L. Dirikolu, Thomas Tobin, Andreas F. Lehner, J. Boyles, J. D. Harkins, W. G. Carter, W. Karpiesiuk, W. E. Woods
Publikováno v:
Journal of Veterinary Pharmacology and Therapeutics. 24:89-98
This report evaluates the pharmacological responses, urinary detection and mass spectral confirmation of ropivacaine in horses. Ropivacaine, a potent local anesthetic (LA) recently introduced in human medicine, has an estimated highest no-effect dose